Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Drug Induced Liver Disease
When do you pursue liver biopsy for assessment of DILI?
Related Questions
How would you approach the management of drug-induced autoimmune hepatitis compared to non-drug-induced autoimmune hepatitis?
How do you counsel patients on the use and risks of alternative medications and supplements given how prevalent and easily accessible they are to the average person?
What role do you see for albumin infusions in patients with hypoalbuminemia to help assist in volume status, outside of its use in replenishment after a large volume paracentesis or renal dysfunction?
Do you always consider ADPCKD or ARPCKD in a patient who is incidentally found to have liver and renal cysts?
How do you determine which patients are good candidates to have their organ receive machine perfusion therapy before implantation?
What would be the right patient profile and experience for someone who may have (operational) tolerance and how do you approach immunosuppresison management (or withdrawal) in this patient?
What management considerations do you keep in mind in the management of pregnant patients with autoimmune liver disease?
What is your approach to the management of post-TIPS hepatic encephalopathy?
What clinical scenario would you favor NOT using terlipressin for the management of HRS if there were no notable contraindications for its initiation?
What are your biggest takeaways from the MASH-TAG 2025 conference?
